Literature DB >> 11579260

AIDS-associated mild neurocognitive impairment is delayed in the era of highly active antiretroviral therapy.

R Deutsch1, R J Ellis, J A McCutchan, T D Marcotte, S Letendre, I Grant.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11579260     DOI： 10.1097/00002030-200109280-00027

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  19 in total

1.  Meeting practical challenges of a trial involving a multitude of treatment regimens: an example of a multi-center randomized controlled clinical trial in neuroAIDS.

Authors:  Susanne May; Scott Letendre; Richard Haubrich; J Allen McCutchan; Robert Heaton; Edmund Capparelli; Ronald Ellis
Journal:  J Neuroimmune Pharmacol       Date:  2007-01-10       Impact factor: 4.147

2.  Oxidative stress and toxicity induced by the nucleoside reverse transcriptase inhibitor (NRTI)--2',3'-dideoxycytidine (ddC): relevance to HIV-dementia.

Authors:  Wycliffe O Opii; Rukhsana Sultana; Hafiz Mohmmad Abdul; Mubeen Ahmad Ansari; Avindra Nath; D Allan Butterfield
Journal:  Exp Neurol       Date:  2006-10-25       Impact factor: 5.330

3.  Heavy alcohol consumption in individuals with HIV infection: effects on neuropsychological performance.

Authors:  Johannes C Rothlind; Tanya M Greenfield; Anne V Bruce; Dieter J Meyerhoff; Derek L Flenniken; Joselyn A Lindgren; Michael W Weiner
Journal:  J Int Neuropsychol Soc       Date:  2005-01       Impact factor: 2.892

4.  Neuropsychological Dysfunction among HIV Infected Drug Abusers.

Authors:  Ramani S Durvasula; Charles H Hinkin
Journal:  Am J Infect Dis       Date:  2006

5.  The impact of neuropsychological functioning on adherence to HAART in HIV-infected substance abuse patients.

Authors:  Allison J Applebaum; Laura C Reilly; Jeffrey S Gonzalez; Mark A Richardson; Catherine L Leveroni; Steven A Safren
Journal:  AIDS Patient Care STDS       Date:  2009-06       Impact factor: 5.078

6.  Select resistance-associated mutations in blood are associated with lower CSF viral loads and better neuropsychological performance.

Authors:  George K Hightower; Scott L Letendre; Mariana Cherner; Sarah A Gibson; Ronald J Ellis; Tanya J Wolfson; Anthony C Gamst; Caroline C Ignacio; Robert K Heaton; Igor Grant; Douglas D Richman; Davey M Smith
Journal:  Virology       Date:  2009-09-16       Impact factor: 3.616

7.  Neuropathologic confirmation of definitional criteria for human immunodeficiency virus-associated neurocognitive disorders.

Authors:  Mariana Cherner; Lucette Cysique; Robert K Heaton; Thomas D Marcotte; Ronald J Ellis; Eliezer Masliah; Igor Grant
Journal:  J Neurovirol       Date:  2007       Impact factor: 2.643

Review 8.  Changing patterns in the neuropathogenesis of HIV during the HAART era.

Authors:  T D Langford; S L Letendre; G J Larrea; E Masliah
Journal:  Brain Pathol       Date:  2003-04       Impact factor: 6.508

9.  Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia.

Authors:  Malcolm J Avison; Avindra Nath; Robin Greene-Avison; Frederick A Schmitt; Rodney A Bales; As'ad Ethisham; Richard N Greenberg; Joseph R Berger
Journal:  J Neurovirol       Date:  2004-08       Impact factor: 2.643

10.  Contributors to neuropsychological impairment in HIV-infected and HIV-uninfected opiate-dependent patients.

Authors:  Allison J Applebaum; Michael W Otto; Mark A Richardson; Steven A Safren
Journal:  J Clin Exp Neuropsychol       Date:  2010-11-04       Impact factor: 2.475
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.